BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors.
Paculová H, Kramara J, Šimečková Š, Fedr R, Souček K, Hylse O, Paruch K, Svoboda M, Mistrík M, Kohoutek J.
Paculová H, et al. Among authors: kohoutek j.
Tumour Biol. 2017 Oct;39(10):1010428317727479. doi: 10.1177/1010428317727479.
Tumour Biol. 2017.
PMID: 29025359
Free article.